window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 12, 2025

  • News
  • About Us
Contact Us

IBD

  • Biologics & Biosimilars,Cell & Gene Therapy,Drug Delivery & Formulation

    N4 Pharma reports positive in vivo results from oral IBD gene therapy study using Nuvec

    UK-based biotech N4 Pharma has announced encouraging in vivo results [...]

    June 8, 2025
  • Artificial Intelligence,Clinical Trials,Drug Development,Technology and platforms

    PhaseV and Crohn’s & Colitis Foundation join forces to fast-track IBD clinical trials with AI

    A new collaboration aims to tackle the toughest challenges in [...]

    May 28, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Citi Pharma joins forces with Chinese firm to boost antibiotic production in Pakistan
    Categories: Biologics & Biosimilars, CDMOs & Manufacturing, Regulatory Affairs
  • DEBRA Research and Queen Mary University of London partner to advance drug development for rare skin disorder
    Categories: Drug Development, Partnerships & Funding, Rare Diseases, Research & Development
  • ASP launches instant read steam system for near-immediate sterility assurance
    Categories: Medical devices, Movers & Shakers, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top